Prednicarbate biotransformation in human foreskin keratinocytes and fibroblasts.
- 1 January 1997
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 14 (6) , 793-797
- https://doi.org/10.1023/a:1012162708675
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Topical Glucocorticoids with Improved Risk-Benefit RatioDrug Safety, 1996
- DOUBLE‐BLIND STUDY OF PREDNICARBATE VERSUS FLUOCORTIN BUTYL ESTER IN ATOPIC DERMATITISInternational Journal of Dermatology, 1996
- Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans.Journal of Clinical Investigation, 1995
- Prednicarbate activity and benefit/risk ratio in relation to other topical glucocorticoidsClinical Pharmacology & Therapeutics, 1993
- Studies on the Pharmacokinetics and Metabolism of Prednicarbate after Cutaneous and Oral AdministrationSkin Pharmacology and Physiology, 1993
- 0.25% Prednicarbate cream and the corresponding vehicle induce less skin atrophy than 0.1% betamethasone-17-valerate cream and 0.05% clobetasol-17-propionate creamEuropean Journal of Clinical Pharmacology, 1992
- Topical glucocorticoids of the non-fluorinated double-ester type. Lack of atrophogenicity in normal skin as assessed by high-frequency ultrasound.Acta Dermato-Venereologica, 1992
- Comparative Atrophogenicity Potential of Medium and Highly Potent Topical Glucocorticoids in Cream and Ointment according to Ultrasound AnalysisSkin Pharmacology and Physiology, 1992
- Optimization of the tetrazolium-based colorimetric assay for the measurement of cell number and cytotoxicityInternational Journal of Immunopharmacology, 1988
- [Pharmacokinetics and biotransformation following topical use of the local corticoid prednicarbate].1986